Emily Cheng is an associate of the capital market department of Zhong Lun. Her practice focuses on Hong Kong capital markets matters such as IPOs and listed companies’ general compliance. Emily also advises clients on M&As.

Prior to joining Zhong Lun, Emily worked in another leading PRC firm.

Highlights of Emily's securities offering and other corporate finance transactions include:

• Advised the sponsor on the proposed H-share listing of a leading construction and decoration company on the Main Board of the Hong Kong Stock Exchange
• Assisted the sponsor in conducting preliminary due diligence on the listing of SenseTime Group Inc. on the Hong Kong Stock Exchange
• Assisted WuXi Biologics (Cayman) Inc. in relation to its proposed IPO under Chapter 18A of the Listing Rules on the Main Board of the Hong Kong Stock Exchange
• Assisted MI Ming Mart Holdings Ltd in relation to its proposed transfer from listing on the GEM Board to the Main Board of the Hong Kong Stock Exchange
• Advised China Health Group Limited in relation to its placing of shares
• Advised China Health Group Limited in relation to its recapitalization of shares
• Advised Greentown Service Group Co Ltd in relation to its general compliance matters from a Hong Kong Listing Rules perspective
• Advised Ludashi Holdings Ltd in relation to its general compliance matters from a Hong Kong Listing Rules perspective
• Advised a leading investment holding company in relation to its general compliance matters from a Hong Kong Listing Rules perspective
• Advised Tianjin Capital Environmental Protection Group Company Limited in relation to its general compliance matters from a Hong Kong Listing Rules perspective
• Advised China Health Group Limited in relation to its general compliance matters from a Hong Kong Listing Rules perspective
• Advised a Hong Kong finance company in relation to assignment of loan and securities from a PRC licensed bank

Highlights of Emily’s M&A transactions include:

• Advised a leading oil and gas company in relation to its proposed acquisition of an oil and gas company in Hong Kong
• Advised a veterinary clinic in relation to its transfer of shares to a leading family business in the US
• Advised the Hong Kong subsidiary of a PRC state-owned conglomerate group in relation to its acquisition of a Hong Kong security company
• Advised the Hong Kong subsidiary of a PRC state-owned conglomerate group in relation to its acquisition of a company holding a shopping center in Hong Kong
• Advised China Health Group Limited in relation to its acquisition of a Bermuda pharmaceutical and related products group
• Advised China Health Group Limited in relation to its acquisition of a BVI pharmaceutical R&D and sales group
• Advised an investment company incorporated in Cayman Islands and listed on the Hong Kong Stock Exchange in relation to its proposed acquisition of a Cayman Islands financial service provider
• Advised a leading catering group in Cayman Islands in relation to its acquisition of a catering company in Hong Kong
• Advised a PRC circuit chip company in relation to its acquisition of a Hong Kong company